Dr Jinzi Jason

Guest Contributor
September 16, 2002

Dr Jinzi Jason has been appointed VP research of PhageTech Inc, a Montreal-based developer of antibiotic drugs based on proprietary phage genomics (bacterial viruses). Jason has considerable expertise in small molecule drugs discovery, with previous experience at Immunex, Novartis and Aventis. He holds an MD from Nanjing Univ’s school of medicine and a PhD in cancer biology from the Univ of Tucson….

Vent


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.